The Bioavailability Question
Most peptides are poorly absorbed orally because digestive enzymes break them down before they reach systemic circulation. BPC-157 is unusual — it appears to be active orally in animal studies, possibly because some of its effects occur locally within the GI tract rather than requiring systemic absorption.
When Oral BPC-157 Makes Sense
Oral BPC-157 is typically preferred for gastrointestinal applications — gut healing, intestinal permeability, IBD-related protocols. The compound appears to have meaningful local effects within the digestive system when administered orally, and systemic absorption is less critical for these indications.
When Injectable BPC-157 Makes Sense
For systemic tissue repair goals — tendon healing, ligament repair, muscle recovery, joint health — injectable BPC-157 is typically preferred because it provides reliable systemic bioavailability. The physician can also target injection near specific injury sites for potentially more concentrated local effects.
What Physicians Typically Prescribe
Most physicians prescribe injectable BPC-157 for musculoskeletal recovery applications and oral BPC-157 for GI applications. Some prescribe both simultaneously when a patient has both systemic and GI goals. The specific form depends on your clinical picture — this is a conversation to have with your physician, not a decision to make independently.